Percutaneous Ultrasound-guided Core Needle Biopsy for the Diagnosis of Cardiac Tumors: Optimizing the Treatment Strategy for Patients with Intermural and Pericardial Cardiac Tumors

Overview

Journal Front Oncol

Specialty Oncology

Date 2022 Aug 22

PMID 35992842

Authors

Ying Xie

Zhi-Liang Hong

Yan-Chun Zhao

Sheng Chen

Yu-Cheng Lin

Song-Song Wu

Affiliations

Soon will be listed here.

Abstract

Objective: The aims of this study are to investigate the clinical value and practical safety of ultrasound-guided percutaneous core needle biopsy on diagnosing cardiac tumor and to discuss the treatment strategy for cardiac intermural and pericardial tumors.

Methods: The clinical data were retrospectively collected for patients with intermural and pericardial cardiac tumors. The patients were divided into groups of surgical resection, surgical resection after obtaining pathological tissue by PUS-CNB, and/or radiotherapy according to the treatment modality. Ultrasound-guided aspiration biopsy was divided into cardiac tumor biopsy and extracardiac lesion biopsy according to patient conditions. The surgical time was recorded, and the safety and clinical application value of PUS-CNB for the diagnosis of cardiac tumors were evaluated in terms of complications and satisfaction with pathological sampling.

Results: A total of 18 patient cases were collected, and PUS-CNB of cardiac tumors was performed in 8 cases, with sampling times averaging 15.6 ± 3.0 min. Four cases of cardiac tumors combined with extracardiac tumors were biopsied, with puncture times averaging 13.0 ± 2.9 min. All 12 biopsied patients had no postoperative complications. Except for 1 failed biopsy, the biopsies were successful and the pathological results were consistent with the clinical diagnosis with a satisfaction rate of 91.7%. Except for two cases of surgical resection, the rest were considered for conservative treatment. Surgical resection and/or biopsy were performed in six cases, and two cases were aggravated after surgery. The final pathology of all 17 cardiac tumors was malignant.

Conclusion: PUS-CNB is safe and effective, providing a simple and undemanding method for accurate diagnosis of cardiac intermural and pericardial tumors while avoiding unnecessary open-heart surgery.

Citing Articles

A Review of Needle Navigation Technologies in Minimally Invasive Cardiovascular Surgeries-Toward a More Effective and Easy-to-Apply Process.

Steeg K, Krombach G, Friebe M Diagnostics (Basel). 2025; 15(2).

PMID: 39857081 PMC: 11763737. DOI: 10.3390/diagnostics15020197.

Case Report: Giant left atrial cystic tumor: myxoma or intracardiac blood cyst?.

Xiao W, Qin J, Feng J, Jiang F, Chen X, Cao X Front Cardiovasc Med. 2024; 11:1323890.

PMID: 38420261 PMC: 10899463. DOI: 10.3389/fcvm.2024.1323890.

Multimodality Imaging of Benign Primary Cardiac Tumor.

Lin Y, Wu W, Gao L, Ji M, Xie M, Li Y Diagnostics (Basel). 2022; 12(10).

PMID: 36292232 PMC: 9601182. DOI: 10.3390/diagnostics12102543.

References

Liu D, Dong R . Clinical manifestation and surgical treatment analysis of five cases with biatrial myxoma. Int J Cardiol. 2016; 228:309-312. DOI: 10.1016/j.ijcard.2016.11.171. View

Taguchi S . Comprehensive review of the epidemiology and treatments for malignant adult cardiac tumors. Gen Thorac Cardiovasc Surg. 2018; 66(5):257-262. DOI: 10.1007/s11748-018-0912-3. View

Inage T, Nakajima T, Sata Y, Fujiwara T, Iwasawa S, Takiguchi Y . Intracardiac Tumors With Extracardiac Extension Diagnosed by Endoscopic Ultrasound With Bronchoscope-Guided Fine-Needle Aspiration. Ann Thorac Surg. 2018; 107(1):e5-e7. DOI: 10.1016/j.athoracsur.2018.05.046. View

Taguchi S, Yozu R . Surgery for primary intrapericardial tumors in adults. J Card Surg. 2013; 28(5):529-32. DOI: 10.1111/jocs.12164. View

Strecker T, Rosch J, Weyand M, Agaimy A . Primary and metastatic cardiac tumors: imaging characteristics, surgical treatment, and histopathological spectrum: a 10-year-experience at a German heart center. Cardiovasc Pathol. 2012; 21(5):436-43. DOI: 10.1016/j.carpath.2011.12.004. View

Gupta K, Mathur V . Diagnosis of pericardial disease using percutaneous biopsy: case report and literature review. Tex Heart Inst J. 2003; 30(2):130-3. PMC: 161899. View

Palaskas N, Thompson K, Gladish G, Agha A, Hassan S, Iliescu C . Evaluation and Management of Cardiac Tumors. Curr Treat Options Cardiovasc Med. 2018; 20(4):29. DOI: 10.1007/s11936-018-0625-z. View

Daliri A, Oehring K, Moosdorf R, Franke F, Kalinowski M, Zahedi F . Percutaneous left atrial cardiac biopsy with CT fluoroscopy guidance. J Vasc Interv Radiol. 2007; 18(7):909-13. DOI: 10.1016/j.jvir.2007.02.032. View

Oliveira G, Al-Kindi S, Hoimes C, Park S . Characteristics and Survival of Malignant Cardiac Tumors: A 40-Year Analysis of >500 Patients. Circulation. 2015; 132(25):2395-402. DOI: 10.1161/CIRCULATIONAHA.115.016418. View

10.

Tyebally S, Chen D, Bhattacharyya S, Mughrabi A, Hussain Z, Manisty C . Cardiac Tumors: State-of-the-Art Review. JACC CardioOncol. 2021; 2(2):293-311. PMC: 8352246. DOI: 10.1016/j.jaccao.2020.05.009. View

11.

Travis W, Brambilla E, Burke A, Marx A, Nicholson A . Introduction to The 2015 World Health Organization Classification of Tumors of the Lung, Pleura, Thymus, and Heart. J Thorac Oncol. 2015; 10(9):1240-1242. DOI: 10.1097/JTO.0000000000000663. View

12.

Burkett B, Arghami A, Bois M, Breen J, Young J . Computed tomographically guided transthoracic biopsy of a cardiac mass in the right ventricular outflow tract. J Thorac Cardiovasc Surg. 2019; 159(2):e115-e118. DOI: 10.1016/j.jtcvs.2019.05.053. View

13.

Bauner K, Sourbron S, Picciolo M, Schmitz C, Theisen D, Sandner T . MR first pass perfusion of benign and malignant cardiac tumours-significant differences and diagnostic accuracy. Eur Radiol. 2011; 22(1):73-82. DOI: 10.1007/s00330-011-2245-9. View

14.

Sakakibara S, Konno S . Endomyocardial biopsy. Jpn Heart J. 1962; 3:537-43. DOI: 10.1536/ihj.3.537. View

15.

Steger C, Hager T, Ruttmann E . Primary cardiac tumours: a single-center 41-year experience. ISRN Cardiol. 2012; 2012:906109. PMC: 3391967. DOI: 10.5402/2012/906109. View

16.

Araoz P, EKLUND H, Welch T, Breen J . CT and MR imaging of primary cardiac malignancies. Radiographics. 1999; 19(6):1421-34. DOI: 10.1148/radiographics.19.6.g99no031421. View

17.

Maurer A, Burshteyn M, Adler L, Steiner R . How to differentiate benign versus malignant cardiac and paracardiac 18F FDG uptake at oncologic PET/CT. Radiographics. 2011; 31(5):1287-305. DOI: 10.1148/rg.315115003. View

18.

ODonnell D, Abbara S, Chaithiraphan V, Yared K, Killeen R, Cury R . Cardiac tumors: optimal cardiac MR sequences and spectrum of imaging appearances. AJR Am J Roentgenol. 2009; 193(2):377-87. DOI: 10.2214/AJR.08.1895. View

19.

Grebenc M, Rosado de Christenson M, Burke A, Green C, Galvin J . Primary cardiac and pericardial neoplasms: radiologic-pathologic correlation. Radiographics. 2000; 20(4):1073-103; quiz 1110-1, 1112. DOI: 10.1148/radiographics.20.4.g00jl081073. View

20.

Yi J, Yoon H, O J, Youn H . Cardiac and Pericardial F-FDG Uptake on Oncologic PET/CT: Comparison with Echocardiographic Findings. J Cardiovasc Imaging. 2018; 26(2):93-102. PMC: 6024833. DOI: 10.4250/jcvi.2018.26.e10. View